Clinicopathological Characteristics of IgG4-Related Disease Involving Uterus and Abdominopelvic Lymph Nodes: A Case Report.

Int J Surg PatholMar 31, 2026 (epub)

Gong Qingyun, Wang Yuanyuan

✦ AI-curated · Sources linked

Case in brief

A 51-year-old woman with prolonged menstruation had PET/CT findings of hypermetabolic uterine masses and multiple abdominopelvic lymph nodes, initially raising concern for malignancy. After total hysterectomy and lymph node biopsy, histology showed storiform fibrosis, obliterative phlebitis, and dense lymphoplasmacytic infiltrates containing abundant IgG4-positive plasma cells. Markedly elevated serum IgG4 and IgG supported IgG4-related disease (IgG4-RD). Following postoperative treatment with dexamethasone, cyclophosphamide, and bortezomib, serum IgG4 levels substantially decreased.

What made this case unusual

IgG4-RD involved both the uterus and abdominopelvic lymph nodes, with imaging that initially suggested malignancy.

Diagnostic / clinical pearl

In atypical pelvic masses, consider IgG4-RD and assess tissue morphology, IgG4-positive plasma cells, and serum immunoglobulin levels together.

Source

Published in Int J Surg Pathol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pathology (Anatomic & Clinical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.